Optimistic for greatly increased treatment access in several years
$MIRA Pharmaceuticals(MIRA.US$ Announces Positive Preclinical Study Results for Its Novel Oral Ketamine Analog, Ketamir-2, Paving Way for Ind Submission Later This Year
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Investing primarily in bio-tech and drug development; both big pharma for growth and start-ups for speculation
14Followers
16Following
35Visitors
Follow